Lexicon Pharmaceuticals LXRX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's interest coverage?
- Lexicon Pharmaceuticals (LXRX) reported interest coverage of -3.5× in Q1 2026.
- How has Lexicon Pharmaceuticals's interest coverage changed year-over-year?
- Lexicon Pharmaceuticals's interest coverage increased by 74.8% year-over-year, from -14.1× to -3.5×.
- What is the long-term trend for Lexicon Pharmaceuticals's interest coverage?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's interest coverage has grown at a 12.3% compound annual growth rate (CAGR), from -3.3× to -5.9×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.